Dennis Slamon
Institution Name:
University of California, Los Angeles
Total Awards:
2
Award Value:
$25,663,353
Awards as PI
| Program Type | Institution | Grant Title | Award Value |
|---|---|---|---|
| Disease Team Research I | University of California, Los Angeles | Therapeutic Opportunities To Target Tumor Initiating Cells in Solid Tumors | $19,979,660 |
| Disease Team Therapy Development III | University of California, Los Angeles | A Phase I dose escalation and expansion clinical trial of the novel first-in-class Polo-like Kinase 4 (PLK4) inhibitor, CFI-400945 in patients with advanced solid tumors | $5,683,693 |
Total: $25,663,353.00 |
